AA

Anjali Agarwalla

Active Director Director DIN 09114758
DIN 09114758 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Anjali Agarwalla

Data last updated:

Anjali Agarwalla is a Director at Megmento Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Megmento Pharmaceuticals Private Limited reported revenue of ₹2.10 Cr (FY 2024).

DIN 09114758
Primary Designation Director
Industry Pharma
First Appointment 19 Mar 2021
Oldest Company Age 5 yrs
Largest company Megmento Pharmaceuticals Private Limited · ₹2.10 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Mar 20212021₹2.10 Cr (FY 2024)Active

Board colleagues of Anjali Agarwalla

Directorship timeline

Open interactive timeline →
Megmento Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anjali Agarwalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Agarwalla

Anjali Agarwalla currently holds 1 directorship: Megmento Pharmaceuticals Private Limited (Director, since 19 Mar 2021, revenue ₹2.10 Cr (FY 2024)).

Anjali Agarwalla was first appointed on 19 Mar 2021 as Director at Megmento Pharmaceuticals Private Limited.

The current boards of Anjali Agarwalla's companies include Karishma Sharma (Megmento Pharmaceuticals Private Limited), Prabhat Kumar Choubey (Megmento Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available